Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Japan
/
Pharmaceuticals & Biotech
/
Otsuka Holdings
4578
Otsuka Holdings
Digital Health And Aging Trends Will Open Markets Despite Risks
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 11 Analysts
Published
05 Jun 25
Updated
15 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
JP¥11,000.00
26.7% undervalued
intrinsic discount
15 Aug
JP¥8,068.00
Loading
1Y
-4.0%
7D
0.8%
Author's Valuation
JP¥11.0k
26.7% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
JP¥11.0k
26.7% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
3t
2014
2017
2020
2023
2025
2026
2028
Revenue JP¥2.9t
Earnings JP¥347.0b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
1.94%
Pharma revenue growth rate
0.55%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
4.72%
Calculation
JP¥347.04b
Earnings '28
x
17.69x
PE Ratio '28
=
JP¥6.14t
Market Cap '28
JP¥6.14t
Market Cap '28
/
486.18m
No. shares '28
=
JP¥12.63k
Share Price '28
JP¥12.63k
Share Price '28
Discounted to 2025 @ 4.72% p.a.
=
JP¥11.00k
Fair Value '25